Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure

Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure

Recent pharmacokinetic studies have suggested that nonrenal clearance predominates the elimination of polymyxin B. We present 2 patients with preexisting end stage renal failure, who were given nonattenuated doses of polymyxin B for the treatment of extreme-drug resistant organism. No evidence of ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Yvonne Peijun Zhou, Nathalie Grace Sy Chua, Maciej Piotr Chlebicki, Winnie Hui Ling Lee, Andrea Lay Hoon Kwa
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2014/573279
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items